Yichang Hec Changjiang Pharmaceutical Co. Ltd. held an Extraordinary General Meeting and the H Shareholders' Class Meeting on 21 July 2025. The proposals discussed included the conditional privatization of the company by Sunshine Lake Pharma Co., Ltd. through a merger by absorption, the proposed withdrawal of listing and last day of trading, and a proposed special dividend. All proposals were approved.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yichang Hec Changjiang Pharmaceutical Co. Ltd. published the original content used to generate this news brief on July 21, 2025, and is solely responsible for the information contained therein.